{"id":"administration-of-albendazole-on-day-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Elevated liver enzymes"}]},"_chembl":{"chemblId":"CHEMBL1483","moleculeType":"Small molecule","molecularWeight":"265.34"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Albendazole is a benzimidazole anthelmintic that selectively binds to β-tubulin in nematodes and other helminths, preventing microtubule assembly and function. This disrupts glucose uptake and energy metabolism in the parasite, leading to immobilization and eventual death. The drug has selective toxicity for parasites over mammalian cells due to differential tubulin binding affinity.","oneSentence":"Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cellular structure and causing paralysis and death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:19:36.652Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Soil-transmitted helminth infections (roundworm, hookworm, whipworm)"},{"name":"Lymphatic filariasis"},{"name":"Onchocerciasis (river blindness)"},{"name":"Cysticercosis"},{"name":"Echinococcosis"}]},"trialDetails":[{"nctId":"NCT06282315","phase":"PHASE3","title":"Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness","status":"RECRUITING","sponsor":"Insud Pharma","startDate":"2025-09-01","conditions":"Soil-Transmitted Helminths","enrollment":20000},{"nctId":"NCT04713787","phase":"PHASE2","title":"A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults","status":"RECRUITING","sponsor":"Asociacion Benefica Prisma","startDate":"2024-09-07","conditions":"Trichuriasis","enrollment":249},{"nctId":"NCT05571280","phase":"NA","title":"Community-based, Controlled, Open-label, Cluster-randomized Trial for the Reduction of Chronic Malnutrition in Children Under Two Years of Age, With Three Intervention Arms Grouped by Clusters, in Two Provinces in Southern Angola, Huíla and Cunene.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2022-10-10","conditions":"Malnutrition, Child","enrollment":1423},{"nctId":"NCT06182176","phase":"NA","title":"Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2024-05-27","conditions":"Malaria, Soil Transmitted Helminths, Schistosomiasis","enrollment":1200},{"nctId":"NCT02947581","phase":"PHASE3","title":"Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)","status":"TERMINATED","sponsor":"Universidad Peruana Cayetano Heredia","startDate":"2016-11-14","conditions":"Neurocysticercosis","enrollment":107},{"nctId":"NCT03570814","phase":"PHASE4","title":"Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-12-01","conditions":"Trachoma, Lymphatic Filariases","enrollment":13511},{"nctId":"NCT05354258","phase":"NA","title":"Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2022-06-16","conditions":"Malaria, Soil Transmitted Helminths, Schistosomiasis","enrollment":600},{"nctId":"NCT03177993","phase":"NA","title":"Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-07-13","conditions":"Lymphatic Filariases, Scabies, Impetigo","enrollment":4773},{"nctId":"NCT01785680","phase":"NA","title":"Moderate Acute Malnutrition (MAM) and Severe Acute Malnutrition (SAM) in Sierra Leone","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-01","conditions":"Malnutrition","enrollment":1957},{"nctId":"NCT03676140","phase":"PHASE3","title":"Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2018-10-01","conditions":"Trachoma, Yaws, Lymphatic Filariases","enrollment":20000},{"nctId":"NCT00290823","phase":"PHASE3","title":"Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-04","conditions":"Neurocysticercosis","enrollment":110},{"nctId":"NCT00507221","phase":"NA","title":"Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression","status":"COMPLETED","sponsor":"University of Washington","startDate":"2008-02","conditions":"HIV Infections, Helminthiasis","enrollment":948},{"nctId":"NCT01903057","phase":"PHASE4","title":"Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2014-02","conditions":"Trachoma, Lymphatic Filariasis","enrollment":""},{"nctId":"NCT01440608","phase":"NA","title":"Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental Enteropathy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2011-10","conditions":"Enteropathy","enrollment":225},{"nctId":"NCT01459146","phase":"PHASE4","title":"Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana","status":"UNKNOWN","sponsor":"Navrongo Health Research Centre, Ghana","startDate":"2010-12","conditions":"Malaria, Schistosomiasis, Helminthiasis","enrollment":345},{"nctId":"NCT00817713","phase":"NA","title":"Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?","status":"TERMINATED","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2009-01","conditions":"HIV Infections, Helminthiasis","enrollment":295}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Administration of Albendazole on Day 1","genericName":"Administration of Albendazole on Day 1","companyName":"London School of Hygiene and Tropical Medicine","companyId":"london-school-of-hygiene-and-tropical-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cellular structure and causing paralysis and death. Used for Soil-transmitted helminth infections (roundworm, hookworm, whipworm), Lymphatic filariasis, Onchocerciasis (river blindness).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}